Standard oral nutritional supplements represent 46.7% of the route of administration category, liquid RTD formats account for 52.2% of form demand and disease-related malnutrition holds 27.9% of indication sales in 2026. The oral clinical nutrition supplement market is projected to post a 4.9% CAGR between 2026 and 2036.